[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Metformin Hydrochloride Market Status and Trend Analysis 2017-2026 (COVID-19 Version)

January 2020 | 106 pages | ID: MB819014278CEN
99Strategy

US$ 3,000.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
SUMMARY


Further key aspects of the report indicate that:
Chapter 1: Research Scope: Product Definition, Type, End-Use & Methodology
Chapter 2: Global Industry Summary
Chapter 3: Market Dynamics
Chapter 4: Global Market Segmentation by region, type and End-Use
Chapter 5: North America Market Segmentation by region, type and End-Use
Chapter 6: Europe Market Segmentation by region, type and End-Use
Chapter 7: Asia-Pacific Market Segmentation by region, type and End-Use
Chapter 8: South America Market Segmentation by region, type and End-Use
Chapter 9: Middle East and Africa Market Segmentation by region, type and End-Use.
Chapter 10: Market Competition by Companies
Chapter 11: Market forecast and environment forecast.
Chapter 12: Industry Summary.

The global Metformin Hydrochloride market has the potential to grow with xx million USD with growing CAGR in the forecast period from 2021f to 2026f. Factors driving the market for @@@@@ are the significant development of demand and improvement of COVID-19 and geo-economics.

Based on the type of product, the global Metformin Hydrochloride market segmented into
  • Metformin HCL
  • Metformin DC
  • Others
Based on the end-use, the global Metformin Hydrochloride market classified into
  • Metformin Hydrochloride Tablets
  • Metformin Hydrochloride Extended-Release Tablets
  • Others Form
Based on geography, the global Metformin Hydrochloride market segmented into
  • North America [U.S., Canada, Mexico]
  • Europe [Germany, UK, France, Italy, Rest of Europe]
  • Asia-Pacific [China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific]
  • South America [Brazil, Argentina, Rest of Latin America]
  • Middle East & Africa [GCC, North Africa, South Africa, Rest of Middle East and Africa]
And the major players included in the report are
  • Bristol-Mayers Squibb
  • Shouguang Fukang Pharmaceutical
  • Harman Finochem
  • Vistin Pharma
  • CR Double-Crane
  • Keyuan Pharmaceutical
  • FARMHISPANIA GROUP
  • Shijiazhuang Polee Pharmaceutical
  • Merck Sante
  • Aarti Drugs
  • TEVA
  • Taj API
  • Wanbury
1 RESEARCH SCOPE

1.1 Research Product Definition
1.2 Research Segmentation
  1.2.1 Product Type
  1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology

2 GLOBAL METFORMIN HYDROCHLORIDE INDUSTRY

2.1 Summary about Metformin Hydrochloride Industry
2.2 Metformin Hydrochloride Market Trends
  2.2.1 Metformin Hydrochloride Production & Consumption Trends
  2.2.2 Metformin Hydrochloride Demand Structure Trends
2.3 Metformin Hydrochloride Cost & Price

3 MARKET DYNAMICS

3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
  3.2.1 Drivers
  3.2.2 Restraints
  3.2.3 Opportunity
  3.2.4 Risk

4 GLOBAL MARKET SEGMENTATION

4.1 Region Segmentation (2017 to 2021f)
  4.1.1 North America (U.S., Canada and Mexico)
  4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
  4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
  4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
  4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
  4.2.1 Metformin HCL
  4.2.2 Metformin DC
  4.2.3 Others
4.3 Consumption Segmentation (2017 to 2021f)
  4.3.1 Metformin Hydrochloride Tablets
  4.3.2 Metformin Hydrochloride Extended-Release Tablets
  4.3.3 Others Form

5 NORTH AMERICA MARKET SEGMENT

5.1 Region Segmentation (2017 to 2021f)
  5.1.1 U.S.
  5.1.2 Canada
  5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
  5.2.1 Metformin HCL
  5.2.2 Metformin DC
  5.2.3 Others
5.3 Consumption Segmentation (2017 to 2021f)
  5.3.1 Metformin Hydrochloride Tablets
  5.3.2 Metformin Hydrochloride Extended-Release Tablets
  5.3.3 Others Form
5.4 Impact of COVID-19 in North America

6 EUROPE MARKET SEGMENTATION

6.1 Region Segmentation (2017 to 2021f)
  6.1.1 Germany
  6.1.2 UK
  6.1.3 France
  6.1.4 Italy
  6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
  6.2.1 Metformin HCL
  6.2.2 Metformin DC
  6.2.3 Others
6.3 Consumption Segmentation (2017 to 2021f)
  6.3.1 Metformin Hydrochloride Tablets
  6.3.2 Metformin Hydrochloride Extended-Release Tablets
  6.3.3 Others Form
6.4 Impact of COVID-19 in Europe

7 ASIA-PACIFIC MARKET SEGMENTATION

7.1 Region Segmentation (2017 to 2021f)
  7.1.1 China
  7.1.2 India
  7.1.3 Japan
  7.1.4 South Korea
  7.1.5 Southeast Asia
  7.1.6 Australia
  7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
  7.2.1 Metformin HCL
  7.2.2 Metformin DC
  7.2.3 Others
7.3 Consumption Segmentation (2017 to 2021f)
  7.3.1 Metformin Hydrochloride Tablets
  7.3.2 Metformin Hydrochloride Extended-Release Tablets
  7.3.3 Others Form
7.4 Impact of COVID-19 in Europe

8 SOUTH AMERICA MARKET SEGMENTATION

8.1 Region Segmentation (2017 to 2021f)
  8.1.1 Brazil
  8.1.2 Argentina
  8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
  8.2.1 Metformin HCL
  8.2.2 Metformin DC
  8.2.3 Others
8.3 Consumption Segmentation (2017 to 2021f)
  8.3.1 Metformin Hydrochloride Tablets
  8.3.2 Metformin Hydrochloride Extended-Release Tablets
  8.3.3 Others Form
8.4 Impact of COVID-19 in Europe

9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION

9.1 Region Segmentation (2017 to 2021f)
  9.1.1 GCC
  9.1.2 North Africa
  9.1.3 South Africa
  9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
  9.2.1 Metformin HCL
  9.2.2 Metformin DC
  9.2.3 Others
9.3 Consumption Segmentation (2017 to 2021f)
  9.3.1 Metformin Hydrochloride Tablets
  9.3.2 Metformin Hydrochloride Extended-Release Tablets
  9.3.3 Others Form
9.4 Impact of COVID-19 in Europe

10 COMPETITION OF MAJOR PLAYERS

10.1 Brief Introduction of Major Players
  10.1.1 Bristol-Mayers Squibb
  10.1.2 Shouguang Fukang Pharmaceutical
  10.1.3 Harman Finochem
  10.1.4 Vistin Pharma
  10.1.5 CR Double-Crane
  10.1.6 Keyuan Pharmaceutical
  10.1.7 FARMHISPANIA GROUP
  10.1.8 Shijiazhuang Polee Pharmaceutical
  10.1.9 Merck Sante
  10.1.10 Aarti Drugs
  10.1.11 TEVA
  10.1.12 Taj API
  10.1.13 Wanbury
10.2 Metformin Hydrochloride Sales Date of Major Players (2017-2020e)
  10.2.1 Bristol-Mayers Squibb
  10.2.2 Shouguang Fukang Pharmaceutical
  10.2.3 Harman Finochem
  10.2.4 Vistin Pharma
  10.2.5 CR Double-Crane
  10.2.6 Keyuan Pharmaceutical
  10.2.7 FARMHISPANIA GROUP
  10.2.8 Shijiazhuang Polee Pharmaceutical
  10.2.9 Merck Sante
  10.2.10 Aarti Drugs
  10.2.11 TEVA
  10.2.12 Taj API
  10.2.13 Wanbury
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation

11 MARKET FORECAST

11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
  11.3.1 Impact of COVID-19
  11.3.2 Geopolitics Overview
  11.3.3 Economic Overview of Major Countries

12 REPORT SUMMARY STATEMENT
LIST OF TABLES
1.Table Metformin Hydrochloride Product Type Overview
2.Table Metformin Hydrochloride Product Type Market Share List
3.Table Metformin Hydrochloride Product Type of Major Players
4.Table Brief Introduction of Bristol-Mayers Squibb
5.Table Brief Introduction of Shouguang Fukang Pharmaceutical
6.Table Brief Introduction of Harman Finochem
7.Table Brief Introduction of Vistin Pharma
8.Table Brief Introduction of CR Double-Crane
9.Table Brief Introduction of Keyuan Pharmaceutical
10.Table Brief Introduction of FARMHISPANIA GROUP
11.Table Brief Introduction of Shijiazhuang Polee Pharmaceutical
12.Table Brief Introduction of Merck Sante
13.Table Brief Introduction of Aarti Drugs
14.Table Brief Introduction of TEVA
15.Table Brief Introduction of Taj API
16.Table Brief Introduction of Wanbury
17.Table Products & Services of Bristol-Mayers Squibb
18.Table Products & Services of Shouguang Fukang Pharmaceutical
19.Table Products & Services of Harman Finochem
20.Table Products & Services of Vistin Pharma
21.Table Products & Services of CR Double-Crane
22.Table Products & Services of Keyuan Pharmaceutical
23.Table Products & Services of FARMHISPANIA GROUP
24.Table Products & Services of Shijiazhuang Polee Pharmaceutical
25.Table Products & Services of Merck Sante
26.Table Products & Services of Aarti Drugs
27.Table Products & Services of TEVA
28.Table Products & Services of Taj API
29.Table Products & Services of Wanbury
30.Table Market Distribution of Major Players
31.Table Global Major Players Sales Revenue (Million USD) 2017-2020e
32.Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e
33.Table Global Metformin Hydrochloride Market Forecast (Million USD) by Region 2021f-2026f
34.Table Global Metformin Hydrochloride Market Forecast (Million USD) Share by Region 2021f-2026f
35.Table Global Metformin Hydrochloride Market Forecast (Million USD) by Demand 2021f-2026f
36.Table Global Metformin Hydrochloride Market Forecast (Million USD) Share by Demand 2021f-2026f
LIST OF FIGURES
1.Figure Global Metformin Hydrochloride Market Size under the Impact of COVID-19, 2017-2021f (USD Million)
2.Figure Global Metformin Hydrochloride Market by Region under the Impact of COVID-19, 2017-2021f (USD Million)
3.Figure Global Metformin Hydrochloride Market by Product Type under the Impact of COVID-19, 2017-2021f (USD Million)
4.Figure Global Metformin Hydrochloride Market by Demand under the Impact of COVID-19, 2017-2021f (USD Million)
5.Figure Global Metformin Hydrochloride Production by Region under the Impact of COVID-19, 2021-2026 (USD Million)
6.Figure Global Metformin Hydrochloride Consumption by Region under the Impact of COVID-19, 2021-2026 (USD Million)
7.Figure Global Metformin Hydrochloride Consumption by Type under the Impact of COVID-19, 2021-2026 (USD Million)
8.Figure North America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
9.Figure Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
10.Figure Asia-Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
11.Figure South America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
12.Figure Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
13.Figure Metformin HCL Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
14.Figure Metformin DC Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
15.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
16.Figure Metformin Hydrochloride Tablets Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
17.Figure Metformin Hydrochloride Extended-Release Tablets Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
18.Figure Others Form Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
19.Figure U.S. Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
20.Figure Canada Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
21.Figure Mexico Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
22.Figure Metformin HCL Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
23.Figure Metformin DC Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
24.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
25.Figure Metformin Hydrochloride Tablets Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
26.Figure Metformin Hydrochloride Extended-Release Tablets Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
27.Figure Others Form Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
28.Figure Germany Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
29.Figure UK Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
30.Figure France Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
31.Figure Italy Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
32.Figure Rest of Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
33.Figure Metformin HCL Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
34.Figure Metformin DC Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
35.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
36.Figure Metformin Hydrochloride Tablets Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
37.Figure Metformin Hydrochloride Extended-Release Tablets Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
38.Figure Others Form Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
39.Figure China Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
40.Figure India Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
41.Figure Japan Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
42.Figure South Korea Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
43.Figure Southeast Asia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
44.Figure Australia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
45.Figure Rest of Asia Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
46.Figure Metformin HCL Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
47.Figure Metformin DC Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
48.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
49.Figure Metformin Hydrochloride Tablets Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
50.Figure Metformin Hydrochloride Extended-Release Tablets Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
51.Figure Others Form Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
52.Figure Brazil Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
53.Figure Argentina Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
54.Figure Rest of Latin America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
55.Figure Metformin HCL Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
56.Figure Metformin DC Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
57.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
58.Figure Metformin Hydrochloride Tablets Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
59.Figure Metformin Hydrochloride Extended-Release Tablets Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
60.Figure Others Form Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
61.Figure GCC Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
62.Figure North Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
63.Figure South Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
64.Figure Rest of Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
65.Figure Metformin HCL Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
66.Figure Metformin DC Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
67.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
68.Figure Metformin Hydrochloride Tablets Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
69.Figure Metformin Hydrochloride Extended-Release Tablets Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
70.Figure Others Form Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
71.Figure Metformin Hydrochloride Sales Revenue (Million USD) of Bristol-Mayers Squibb 2017-2020e
72.Figure Metformin Hydrochloride Sales Revenue (Million USD) of Shouguang Fukang


More Publications